W
MED icon

WealthCollab’s Medifast MED Stock Holding History

WealthCollab’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12K Sell
110
-229
-68% -$2.47K ﹤0.01% 902
2025
Q4 		$3.62K Buy
339
+163
+93% +$1.95K ﹤0.01% 789
2025
Q3 		$2.41K Buy
176
+86
+96% +$1.2K ﹤0.01% 802
2025
Q2 		$1.26K Buy
90
+63
+233% +$828 ﹤0.01% 875
2025
Q1 		$364 Sell
27
-509
-95% -$7.64K ﹤0.01% 891
2024
Q4 		$9.45K Buy
536
+78
+17% +$1.45K 0.01% 457
2024
Q3 		$8.77K Sell
458
-254
-36% -$4.89K 0.01% 491
2024
Q2 		$15.5K Sell
712
-76
-10% -$2.03K 0.01% 344
2024
Q1 		$30.2K Buy
788
+634
+412% +$30.7K 0.02% 222
2023
Q4 		$10.4K Buy
+154
New +$10.7K 0.01% 406

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

WealthCollab's MED Position: Q1 2026 in Review

WealthCollab reduced its Medifast (MED) stake by 68% in Q1 2026, selling an estimated $2.47K and leaving 110 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #902.

WealthCollab first reported a position in MED in Q4 2023 and has held it in 10 quarters since. The position peaked at $30.2K in Q1 2024. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • WealthCollab held 110 shares of Medifast worth $1.12K as of Q1 2026.
  • WealthCollab sold 229 Medifast shares in Q1 2026, an estimated $2.47K.
  • Medifast made up ﹤0.01% of WealthCollab's portfolio in Q1 2026, its #902 holding.
  • WealthCollab first reported a position in Medifast in Q4 2023 and has held it in 10 quarters since.
  • WealthCollab's Medifast position peaked at $30.2K in Q1 2024.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.